Showing results (901-910 of 5,050) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|September 21, 2016
Prevalence of multiple sclerosis in Health District III, Murcia, SpainAntonio Candeliere-Merlicco, Francisco Valero-Delgado, Salvadora Martínez-Vidal, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studiesGavin Giovannoni, Ludwig Kappos, Ralf Gold, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
How global MS prevalence is changing: A retrospective chart review in the United Arab EmiratesNicoline Schiess, Katherine Huether, Taghreed Fatafta, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Increasing prevalence of multiple sclerosis in Buenos Aires, ArgentinaE Cristiano, L Patrucco, J Miguez, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and designFrancois Curtin, Herve Porchet, Robert Glanzman, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Neuromyelitis optica spectrum disorder coinciding with hematological immune disease: A case reportR Patejdl, M Wittstock, U K Zettl, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Three cases of herpes zoster radiculitis in MS patients treated with natalizumabBassem I Yamout, Nuhad Abou Zeid, Ali J Taha, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
Heterogeneous depression trajectories in multiple sclerosis patientsDouglas D Gunzler, Nathan Morris, Adam Perzynski, et al.
Multiple Sclerosis and Related Disorders|April 10, 2018
Severe CNS inflammation after discontinuation of natalizumab and start of daclizumab successfully treated with alemtuzumabMartin W Hümmert, Julian Deppe, Refik Pul, et al.
Multiple Sclerosis and Related Disorders|April 21, 2018
Lifestyle factors and multiple sclerosis: A population-based incident case-control studyIbrahim Abdollahpour, Saharnaz Nedjat, Mohammad Ali Mansournia, et al.
Pageof 505